濮阳东方看男科病评价很高濮阳东方医院男科治疗阳痿价格正规,濮阳东方医院很靠谱,濮阳东方男科医院割包皮口碑很好,濮阳东方医院妇科好不好,濮阳东方价格偏低,濮阳东方医院割包皮手术技术,濮阳东方妇科医院做人流收费不贵

Mike "Doc" Emrick, the legendary NHL broadcaster who has been calling hockey games for decades, is retiring. The New York Post was the first to report his retirement.“I hope I can handle retirement OK,” Emrick told the New York Post Sunday night. “Especially since I’ve never done it before. But I’ve just been extremely lucky for 50 years. And NBC has been so good to me, especially since the pandemic, when I was allowed to work from home in a studio NBC created."Emrick, who has been broadcasting hockey for 47 seasons, has been the lead play-by-play voice for national NHL broadcasts in the U.S. on Versus and NBC since 2005. He has called 13 Stanley Cup Finals and was inducted to the U.S. Hockey Hall of Fame in 2011, the first member of the media to be inducted.He was also the recipient of the Hockey Hall of Fame Foster Hewitt Memorial Award for outstanding contributions to hockey broadcasting in 2008. 920

Lowe's said Friday it will add 20,000 workers to meet the demand for the upcoming holiday shopping season and beyond.Lowe's said the seasonal jobs would work in stores across the U.S. and its regional distribution centers in a press release to help with the upcoming holiday season. The home improvement company also said they are looking to fill full-time and part-time positions inside stores and hire 2,500 for their regional distribution centers."As the holiday season approaches, we're especially grateful for our front-line associates who continue to maintain the highest level of customer service, and this bonus is our way of saying thank you and providing a little extra financial support for their families during this time," said Marvin R. Ellison, Lowe's president, and CEO in the news release. "We're also pleased to continue hiring for more than 20,000 roles across our stores and supply chain during a time when it's more important than ever to make being home for the holidays special."Lowe's also announced Friday that they are giving 0 million in bonuses to employees, which is the company's sixth pandemic-related associate bonus.The company said full-time hourly associates would receive 0, and part-time and seasonal associates will receive a 0 bonus on Nov. 13. 1300

Mass transit systems around the world have taken sweeping steps to curb the spread of the coronavirus, including shutting down some subways overnight and testing powerful ultraviolet lamps to disinfect seats, poles and floors. But experts say those steps solve only part of the problem because the virus is more often spread through the air. Transit officials are studying more advanced cleaning methods that might someday automatically disinfect transit systems around the clock. The Moscow Metro and a public bus company in Shanghai have experimented with germ-killing ultraviolet light. Agencies in Hungary and the Czech Republic have tried using ozone gas as a disinfectant. 686

Major 2020 election news will likely take place with Democratic nominee Joe Biden set to reveal his pick for vice president. THE PROCESSThe Biden team has been very secretive with the vetting process like previous presidential campaigns. According to sources, many top-level advisers are not even privileged to the selection process. Biden said months ago he would pick a woman to be his running mate but has not narrowed it down any further. THE POSSIBLE PICKSWhile it is possible Biden will pick someone not on this list, it is expected he will choose from these 11 women: Stacey Abrams: A former legislator in Georgia who came close to winning the Governor's Race in Georgia in 2018. Abrams is an African American leader and viewed as a rising star but some question whether she has enough national experience. Tammy Baldwin: A United States senator representing the swing state of Wisconsin, but some question whether she has had enough exposure on the national stage. Karen Bass: A member of the House of Representatives representing California, Bass is an experienced legislator and African-American leader. Being from California, however, doesn't help with swing states.Keisha Lance Bottoms: Mayor of Atlanta and an African-American leader, Bottoms, however, has limited national experience. Val Demings: A member of Congress from the crucial state of Florida, Demings is a prominent member of the Congressional Black Caucus who gained exposure during the impeachment of President Donald Trump. Some attack her time as a police chief, however. Tammy Duckworth: A United States senator representing Illinois, Duckworth is also a veteran. Some wonder if she is well-known enough. Michelle Lujan Grisham: As governor of New Mexico and a former Member of Congress, Grisham has the experience and is one of the nation's top Latinas. Critics point to the fact few know her outside of New Mexico. Kamala Harris: A United States senator and African-American leader, Harris is well-known as a former presidential candidate. Some Biden advisers don't like how she attacked Biden during the campaign, not to mention her time as a prosecutor could hurt her with some voters. Susan Rice: An African-American woman who served as former National Security Adviser under President Obama, Rice has qualifications but has never held elected office. Gretchen Whitmer: Whitmer leads the swing state of Michigan as governor but some question whether Biden should pick an African-American to serve as his number two. Elizabeth Warren: Warren is well-known on the national stage as a progressive, which could help turn out for Joe Biden. However, she is also a lightning rod for conservatives. 2686

Many people across the country are full of hope now that a few COVID-19 vaccines are showing positive results, and they appear to be highly effective. But will Americans be willing to get a shot?Before Pfizer, Moderna and Astra Zeneca shared their results, Gallup Economics conducted a poll with Franklin-Templeton on what it would take for Americans to be willing to get a COVID-19 vaccine."We decided to dig deeper to why people are skeptical of a vaccine and see what pieces of information make a difference in effecting their decision in getting it or not," said Jonathan Rothwell, the Principal Economist at Gallup. Rothwell says, instead of a traditional Gallup Poll with multiple choice or open-ended questions, the more than 5,000 people surveyed were broken into groups of 200. Each group was asked different questions, proposing various scenarios and hypotheticals about a vaccine."'Imagine there's a vaccine that's going to be widely available in either', and then we varied the timing to be either the end of this year or beginning of next year. We varied whether we disclosed if it came after the FDA did three rounds of clinical trials or mention it was FDA approved," said Rothwell. People were also asked about how effective a vaccine would need to be and who would have to recommend it in order to take it."I would say the most surprising thing was telling people the Food and Drug Administration approved the vaccine after three rounds of clinical trials had a slightly negative, not significant effect relative to just telling them it's just FDA approved," said Rothwell.The results also showed African-Americans and Hispanics were more skeptical of a COVID-19 vaccine and that most people wouldn't resume activities like going to the store without a mask, traveling, or sending their kids back to school just because a COVID-19 vaccine was available.Dr. Bali Pulendran, a professor of microbiology and immunology at Stanford University, says news about the high efficacy of two different COVID-19 vaccines is extremely positive, but he understands people's hesitations."It's understandable because this is unprecedented, no one has developed vaccines at such warp speed. But, again, it has to be driven by the data and what the data shows us now is that at least in the short term, we have these vaccines that are in excess of 90% effective and safe," said Dr. Pulendran.Dr. Pulendran says just because it took less than a year to develop an effective COVID-19 vaccine, doesn't mean corners were cut to get there."The methods used to make these vaccines have gone through the same high rigorous standards that have always been used to make any number of vaccines that have been administered and that have been proven to be safe and effective. By that, I mean they’ve gone through phase one, phase two, phase three human trials, multiple independent bodies have looked at the data," said Dr. Pulendran.Gallup hopes scientists, doctors and politicians will use the results of this poll to help guide their messaging to the general public so that most people will be encouraged to get a COVID-19 vaccine when it becomes available. 3155